Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3

X Zhang1, M S Steiner, A Rinaldy

  • 1Department of Urology, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA.

Oncogene
|October 11, 2001
PubMed

Insights

A novel gene, pHyde, effectively inhibits prostate cancer growth by triggering programmed cell death (apoptosis) through a caspase-3 dependent mechanism. This discovery offers a potential new therapeutic strategy for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer remains a significant health concern with a need for novel therapeutic targets.
  • The identification and characterization of new genes involved in cancer progression are crucial for developing innovative treatments.

Purpose of the Study:

  • To investigate the biological function of the novel gene pHyde in prostate cancer.
  • To determine the mechanism by which pHyde affects cancer cell growth and survival.

Main Methods:

  • Generation of a recombinant adenovirus carrying the pHyde cDNA gene (AdpHyde).
  • Assessment of AdpHyde's effect on human prostate cancer cell growth and induction of apoptosis using DAPI, TUNEL staining, and flow cytometry.
  • Evaluation of AdpHyde's efficacy in human prostate cancer xenograft models in nude mice.
  • Measurement of caspase-3 activity in response to AdpHyde treatment and assessment of pHyde's effect in cells lacking caspase-3 expression.

Main Results:

  • AdpHyde significantly inhibited the growth of human prostate cancer cells.
  • AdpHyde transduction induced apoptosis in cancer cells, confirmed by multiple assays.
  • Treatment with AdpHyde led to apoptosis in human prostate cancer xenografts.
  • A dose-dependent increase in caspase-3 activity was observed following AdpHyde transduction, which was inhibited by specific caspase-3 inhibitors.
  • pHyde's inhibitory effect was diminished in cancer cells lacking endogenous caspase-3.

Conclusions:

  • The novel gene pHyde inhibits prostate cancer growth.
  • pHyde induces apoptosis in prostate cancer cells via a caspase-3 dependent pathway.
  • pHyde represents a potential therapeutic target for prostate cancer treatment.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...